Le Lézard
Classified in: Health
Subjects: TRI, PLW

Patent Exchange to Conduct Sealed-Bid Auction of The Parkinson's Institute & Clinical Center's International Patent Portfolio

Portfolio to Be Sold as One Auction Lot - No Minimum Bid ? No Minimum Reserve Price

Bid Deadline ? March 1, 2023

HIDDEN VALLEY LAKE, Calif., Jan. 19, 2023 /PRNewswire/ -- The Patent Exchange will be conducting a Sealed-Bid Auction of The Parkinson's Institute & Clinical Center's Patent Portfolio (Auction Info) There is no Minimum Bid Price nor is there a Minimum Reserve Price for this auction. All bids in conformance with the terms of the auction are welcome.

The Parkinson's Institute & Clinical Center is selling its international patent portfolio at auction as part of an orderly wind-down of operations.  The Institute provided comprehensive evaluation, treatment and therapy for patients with Parkinson's Disease and conducted extensive clinical research programs to identify the cause of Parkinson's Disease and ways to prevent its progression.

"For 30 years, the Parkinson's Institute conducted groundbreaking research and was a significant contributor to the scientific community.  The result of its work lives on through its many published articles and patents. We are excited to see the good work continued through others who exhibit the passion and scientific rigor required to find a cure for Parkinson's disease. We are all in this together.", said Brian R. Coulter, CEO of The Parkinson's Institute and Clinical Center.

Granted US Patents in the portfolio include:

Patent Analysis Report

Patent Title


Assay to determine LRRK2 Activity in Parkinson's Disease


Pluripotent Cell Lines and Methods of Use Thereof


Pluripotent Cell Lines and Methods of Use Thereof


Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients


Assay to Determine LRRK2 Activity in Parkinson's Disease


Diagnosis of Neurodegenerative Disorders

View Parkinson Institute Patent Portfolio Report

Charitable Allies, a nonprofit legal-aid law firm focusing on the unique needs of nonprofit organizations, represents The Parkinson's Institute in the orderly dissolution process.

The Patent Exchange

The Patent Exchange is a patent auction and brokerage delivering high-exposure marketing campaigns for the "date certain" sale of patents, serving corporate, government and private clientele seeking efficient sale of patents. Sellers benefit by relief from ongoing patent fees and from the recycling of sale proceeds back into new patents.  Buyers benefit from quick acquisition of patents and patent applications and bypassing the cost and time required for the granting of patents.  Society benefits from new owners breathing new life into the patents and bringing them to the marketplace.

Media Contact:

Doug Berman

Managing Director


[email protected] 

SOURCE The Patent Exchange

These press releases may also interest you

at 08:43
In the wake of a severe illness season, Kinsa, an insights solutions business that uses data to predict, prepare for and prevent the spread of illness, today announced the County of San Mateo, California as a new customer of Kinsa's illness insights....

at 08:42
One out of three coronavirus deaths in the United States have been residents or employees of long-term care facilities. Over 400,000 caregivers have left the field of long-term care. Hospitals are "boarding" elderly patients in hallways and emergency...

at 08:37
REIGN Total Body Fuel has unveiled a brand-new energy drink set to take the wellness sphere by storm: introducing REIGN STORM. Experience the full interactive Multichannel News Release here: REIGN Storm is a ZERO SUGAR, low calorie energy drink...

at 08:36
Regent Surgical Health announced today that Erik Kraemer has joined the company as Chief Development Officer (CDO), an addition that strengthens Regent's reputation for partnering with leading health systems across the country to scale their...

at 08:36
TrueBinding, Inc.? a clinical-stage biotherapeutic company creating new and exciting molecules for applications in neurodegenerative and other disease areas with great unmet needs? today announced early results from an Open-Label Extension (OLE)...

at 08:35
Simulations Plus, Inc. , a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that it established a strategic research collaboration with the Sino-American Cancer Foundation...

News published on 19 january 2023 at 08:41 and distributed by: